Literature DB >> 159261

Complement activation in acne vulgaris: consumption of complement by comedones.

G F Webster, J J Leyden, U R Nilsson.   

Abstract

Comedones, the contents of acne lesions, were shown to consume scomplement hemolytic activity in normal serum. This consumption was stimulated by the addition of serum from patients with inflammatory acne. Absorption of acne serum with Propionibacterium acnes cells removed all stimulating activity. Immunoelectrophoretic analysis of serum incubated with comedones revealed the conversion of C3 and factor B in normal serum. The addition of acne serum resulted in cleavage of C4. In serum treated with ethylene glycol-bis(beta-aminoethyl ether)-N,N'-tetraacetic acid, only C3 and factor B were converted. This indicates that comedones may activate complement by either the classical or the alternative pathway. It is suggested that P. acnes cells in comedonal material are responsible for the complement activation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159261      PMCID: PMC414592          DOI: 10.1128/iai.26.1.183-186.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Analysis of the water soluble extract of comedones.

Authors:  L G Hernandez; S M Puhvel
Journal:  J Invest Dermatol       Date:  1978-11       Impact factor: 8.551

2.  An in vivo evaluation of the inflammatory effect of purified comedonal components in human skin.

Authors:  S M Puhvel; M Sakamoto
Journal:  J Invest Dermatol       Date:  1977-10       Impact factor: 8.551

3.  Complement activation by Corynebacterium acnes.

Authors:  A Massey; J F Mowbray; W C Noble
Journal:  Br J Dermatol       Date:  1978-05       Impact factor: 9.302

4.  Complement in inflammatory acne vulgaris.

Authors:  M G Dahl; D H McGibbon
Journal:  Br Med J       Date:  1976-12-04

5.  Inhibition of complement by mouse serum: selective inactivation of the fourth component of human complement.

Authors:  R J Mandle; J A McConnell-Mapes; U R Nilsson
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

Review 6.  An overview of acne.

Authors:  A M Kligman
Journal:  J Invest Dermatol       Date:  1974-03       Impact factor: 8.551

7.  Cleavage products of C4b produced by enzymes in human serum.

Authors:  S Shiraishi; R M Stroud
Journal:  Immunochemistry       Date:  1975-12

8.  Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.

Authors:  G F Webster; J J Leyden; M E Norman; U R Nilsson
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  The chemoattractant properties of comedonal components.

Authors:  S M Puhvel; M Sakamoto
Journal:  J Invest Dermatol       Date:  1978-11       Impact factor: 8.551

  9 in total
  14 in total

1.  Analysis of the proinflammatory property of epidermal cyst contents: chemotactic C5a anaphylatoxin generation.

Authors:  T Terui; M Rokugo; T Kato; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.

Authors:  B R Vowels; S Yang; J J Leyden
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Bacterial resistance to antibiotics in acne vulgaris: an in vitro study.

Authors:  Parvin Hassanzadeh; M Bahmani; Davood Mehrabani
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

5.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

6.  Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.

Authors:  S E Unkles; C G Gemmell
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 7.  Current concepts of the pathogenesis of acne: implications for drug treatment.

Authors:  Harald Gollnick
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

9.  Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes.

Authors:  G F Webster; J J Leyden
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

10.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.